Skip to main content

Blavatnik Len's Form 4 filing

Climb Bio, Inc.CLYM · filed Aug 16, 2021

Accession no.
0001209191-21-051627
Filed
Aug 16, 2021, 4:21 PM ET
Trade date
Aug 12, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $10.0M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Blavatnik LenCIK 0001326628Other: Affiliate of 10% Owner
Access Industries Holdings LLCCIK 0001391297Other: Affiliate of 10% Owner
Access Industries Management, LLCCIK 0001508226Other: Affiliate of 10% Owner
AI Eti LLCCIK 000187174110% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 12, 2021Common StockCConversionAcquired+4,209,400$0.00$04,209,400Direct
Aug 12, 2021Common StockPPurchaseAcquired+800,000$12.50+$10,000,0005,009,400Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 12, 2021Common StockCConversionDisposed−3,568,375$0.00$00Direct
Aug 12, 2021Common StockCConversionDisposed−641,025$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)